The number of people with susceptibility test result for rifampicin in Kiribati
Kiribati: The number of people with susceptibility test result for rifampicin was 96.72 in 2021. ▲ Rising
Latest (2021)
96.72
Change on year
up 6.2%
World rank
41st
of 146 countries
All-time high
100
in 2018
All-time low
0.5494
in 2017
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Kiribati, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
Kiribati recorded 96.72 for the number of people with susceptibility test result for rifampicin in 2021.
The figure is up 6.2% on the previous year and up 17,503.3% over five years.
Kiribati ranks 41st of 146 countries on this measure, in the middle of the range.
The number of people with susceptibility test result for rifampicin in Kiribati, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 0.5494 | — |
| 2018 | 100 | +18100.0% |
| 2019 | 100 | +0.0% |
| 2020 | 91.1 | -8.9% |
| 2021 | 96.72 | +6.2% |
Kiribati compared with similar countries
- Kiribati's 96.72 is above the median for lower middle income countries, which is 78.77, 1.2× the median. (32 countries reporting)
- Kiribati's 96.72 is above the median for East Asia & Pacific, which is 96.47, 1.0× the median. (28 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 66.85 | 0.5494 | 100 | 3 |
| 2020s | 93.91 | 91.1 | 96.72 | 2 |
Countries ranked near Kiribati
More health data for Kiribati
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.7209 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,076 deaths per 1,000 people (2090)
- Number of infants who die before age 1 34 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -0.3672 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0576 units per person (2025)
- Population ages 00-04, male, annual growth rate -0.3464 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Kiribati?
- The number of people with susceptibility test result for rifampicin in Kiribati was 96.72 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Kiribati?
- The highest recorded value was 100 in 2018.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Kiribati?
- The lowest recorded value was 0.5494 in 2017.
- How does Kiribati rank for the number of people with susceptibility test result for rifampicin?
- Kiribati ranks 41st out of 146 countries with data for 2021.
- Where does this Kiribati data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).